Yan Hu

1.6k total citations
41 papers, 1.3k citations indexed

About

Yan Hu is a scholar working on Molecular Biology, Cancer Research and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Yan Hu has authored 41 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 8 papers in Cancer Research and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Yan Hu's work include RNA Interference and Gene Delivery (8 papers), RNA Research and Splicing (8 papers) and RNA modifications and cancer (7 papers). Yan Hu is often cited by papers focused on RNA Interference and Gene Delivery (8 papers), RNA Research and Splicing (8 papers) and RNA modifications and cancer (7 papers). Yan Hu collaborates with scholars based in China and United States. Yan Hu's co-authors include Baisong Liao, Gary Brewer, Jinhong Duan, Xian‐Da Yang, David J. Herrick, Haiyan Xu, Wei Yuan, Xin Lu, Chenchen Yu and Chen Wang and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and PLoS ONE.

In The Last Decade

Yan Hu

40 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yan Hu China	19	976	303	164	161	118	41	1.3k
Judong Luo China	18	751 0.8×	452 1.5×	232 1.4×	123 0.8×	84 0.7×	63	1.2k
Heping Li China	19	755 0.8×	503 1.7×	72 0.4×	232 1.4×	92 0.8×	47	1.2k
Chong Du China	18	569 0.6×	323 1.1×	116 0.7×	194 1.2×	49 0.4×	41	898
Junxing Huang China	26	1.0k 1.1×	711 2.3×	160 1.0×	224 1.4×	105 0.9×	82	1.7k
Lian Li China	17	467 0.5×	236 0.8×	269 1.6×	314 2.0×	178 1.5×	40	1.0k
Liwei Ma China	22	643 0.7×	181 0.6×	84 0.5×	177 1.1×	63 0.5×	81	1.2k
Donghai Huang China	24	815 0.8×	377 1.2×	83 0.5×	380 2.4×	144 1.2×	60	1.3k
Andrey Ugolkov United States	24	899 0.9×	325 1.1×	141 0.9×	453 2.8×	121 1.0×	44	1.5k

Countries citing papers authored by Yan Hu

Since Specialization

Citations

This map shows the geographic impact of Yan Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Hu more than expected).

Fields of papers citing papers by Yan Hu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Hu. The network helps show where Yan Hu may publish in the future.

Co-authorship network of co-authors of Yan Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Hu. A scholar is included among the top collaborators of Yan Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Hu. Yan Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Zhichao, Yan Hu, Jun Cai, et al.. (2025). Potential value of novel multiparametric MRI radiomics for preoperative prediction of microsatellite instability and Ki-67 expression in endometrial cancer. Scientific Reports. 15(1). 3226–3226. 3 indexed citations

Hu, Yan, Xinyao Tian, Yan Zhao, et al.. (2023). Sirtuin 5 Alleviates Liver Ischemia/Reperfusion Injury by Regulating Mitochondrial Succinylation and Oxidative Stress. Antioxidants and Redox Signaling. 40(10-12). 616–631. 13 indexed citations

Wang, Fei, Lihui Zhao, Wei Du, Yan Hu, & Yi Ren. (2023). Oral rifampicin interferes with urine dipstick tests for patients with pulmonary tuberculosis. Journal of Thoracic Disease. 15(5). 2636–2643.

Dai, Xiaomeng, Yixuan Guo, Yan Hu, et al.. (2021). Immunotherapy for targeting cancer stem cells in hepatocellular carcinoma. Theranostics. 11(7). 3489–3501. 57 indexed citations

Hu, Yan, et al.. (2021). Differential Expression of COL1A1, COL1A2, COL6A3, and SULF1 as Prognostic Biomarkers in Gastric Cancer. International Journal of General Medicine. Volume 14. 5835–5843. 13 indexed citations

Liu, Xu, Qiongfang Yu, Yan Hu, et al.. (2020). Apatinib regulates the growth of gastric cancer cells by modulating apoptosis and autophagy. Naunyn-Schmiedeberg s Archives of Pharmacology. 394(5). 1009–1018. 12 indexed citations

Zhuang, Yan, Ying Bai, Yan Hu, et al.. (2019). <p>Rhein sensitizes human colorectal cancer cells to EGFR inhibitors by inhibiting STAT3 pathway</p>. OncoTargets and Therapy. Volume 12. 5281–5291. 25 indexed citations

Hu, Yan, Dengke Li, Fan Wu, et al.. (2019). The antibiotic clofoctol suppresses glioma stem cell proliferation by activating KLF13. Journal of Clinical Investigation. 129(8). 3072–3085. 39 indexed citations

Hu, Yan, et al.. (2019). Selection of a novel DNA aptamer against OFA/iLRP for targeted delivery of doxorubicin to AML cells. Scientific Reports. 9(1). 7343–7343. 14 indexed citations

10.

Wang, Xuan, Min Jin, Qingqing Ye, et al.. (2018). Solitary duodenum metastasis from breast cancer with 8 years’ latency. Medicine. 97(2). e9550–e9550. 4 indexed citations

11.

Han, Wei, Peishan Hu, Fan Wu, et al.. (2018). FHL3 links cell growth and self-renewal by modulating SOX4 in glioma. Cell Death and Differentiation. 26(5). 796–811. 27 indexed citations

12.

Hu, Yan, Chengguang Zhao, Hailun Zheng, et al.. (2017). A novel STAT3 inhibitor HO-3867 induces cell apoptosis by reactive oxygen species-dependent endoplasmic reticulum stress in human pancreatic cancer cells. Anti-Cancer Drugs. 28(4). 392–400. 23 indexed citations

13.

Qiu, Chenyu, Yan Hu, Ke Wu, et al.. (2016). Synthesis and biological evaluation of allylated mono-carbonyl analogues of curcumin (MACs) as anti-cancer agents for cholangiocarcinoma. Bioorganic & Medicinal Chemistry Letters. 26(24). 5971–5976. 22 indexed citations

14.

Weng, Qiaoyou, Yan Hu, Haixia Zhou, et al.. (2016). Curcumin analogue, A13, exhibits anti-leukemia effect via inhibiting STAT3. Tumor Biology. 37(7). 9959–9966. 5 indexed citations

15.

Hu, Yan, Junwen Duan, Bangrong Cao, et al.. (2015). Selection of a novel DNA thioaptamer against HER2 structure. Clinical & Translational Oncology. 17(8). 647–656. 20 indexed citations

16.

Hu, Yan, et al.. (2012). Novel MUC1 Aptamer Selectively Delivers Cytotoxic Agent to Cancer Cells In Vitro. PLoS ONE. 7(2). e31970–e31970. 130 indexed citations

17.

Zhou, Hai, Yan Hu, Xin Li, et al.. (2011). Suppression of vascular endothelial growth factor via siRNA interference modulates the biological behavior of human nasopharyngeal carcinoma cells. Japanese Journal of Radiology. 29(9). 615–622. 7 indexed citations

18.

Liao, Baisong, Yan Hu, & Gary Brewer. (2011). RNA-binding Protein Insulin-like Growth Factor mRNA-binding Protein 3 (IMP-3) Promotes Cell Survival via Insulin-like Growth Factor II Signaling after Ionizing Radiation. Journal of Biological Chemistry. 286(36). 31145–31152. 49 indexed citations

19.

Liao, Baisong, Yan Hu, David J. Herrick, & Gary Brewer. (2005). The RNA-binding Protein IMP-3 Is a Translational Activator of Insulin-like Growth Factor II Leader-3 mRNA during Proliferation of Human K562 Leukemia Cells. Journal of Biological Chemistry. 280(18). 18517–18524. 182 indexed citations

20.

Hu, Yan. (2004). Effects of transforming growth factor beta-1 on DNA synthesis of bovine endothelial cells. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Judong Luo Breakdown of academic impact, for papers by Heping Li Breakdown of academic impact, for papers by Chong Du Breakdown of academic impact, for papers by Junxing Huang Breakdown of academic impact, for papers by Lian Li Breakdown of academic impact, for papers by Liwei Ma Breakdown of academic impact, for papers by Donghai Huang Breakdown of academic impact, for papers by Andrey Ugolkov